Looking for leads, investment insights, or competitive intelligence?
News about Roche Group
The finding could result in annual sales of $4.6 billion by 2023.
The FDA approved the first cancer medicine "biosimilar" Thursday.
The pharma giant's shares fell 5% in U.S. trading Monday.
A new FDA approval gives Merck a huge advantage over its rivals.
20 new drugs in 2017 to date. There were just 22 in all of 2016.